Medtronic PLC closed 8.69% short of its 52-week high of $96.25, which the company reached on March 10th.

Medtronic (NYSE:MDT) has appointed a former Dexcom leader as the new head of Americas for its Diabetes business unit.

Medtronic's stock has lost around a third of its value since late 2022. However, stock prices for longtime dividend growers ...

Medtronic (NYSE: MDT) stock was a fairly hot item as the trading week kicked off, with investors pushing the shares up by ...

Medtronic’s latest recall of the Pipeline Vantage 027 and 021 products is likely to result in revenue losses in the ...

In the latest market close, Medtronic (MDT) reached $87.89, with a -1.09% movement compared to the previous day. The stock exceeded the S&P 500, which registered a loss of 4.84% for the day. Meanwhile ...

Medtronic plc (NYSE:MDT – Get Free Report) was the target of unusually large options trading on Friday. Traders acquired ...

Hologic (Nasdaq: HOLX) announced that it appointed Wayde McMillan to its board of directors, effective April 4, 2025.

Bearish flow noted in Medtronic (MDT) with 25,355 puts trading, or 7x expected. Most active are Jun-25 100 calls and Jan-26 85 puts, with total ...

Medtronic says its Evolut TAVR shows strong valve performance and durable outcomes at 5 years in low-risk aortic stenosis ...

In the latest market close, Medtronic (MDT) reached $87.89, with a -1.09% movement compared to the previous day. The stock exceeded the S&P 500, which registered a loss of 4.84% for the day.